Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
$ 21.00 · 5 (175) · In stock
Biomedicines, Free Full-Text
Cancers, Free Full-Text
PD-L1ATTAC mice reveal the potential of depleting PD-L1 expressing
Mice injected with IL-6 Pan02 have a survival advantage over mice
When do we say cure for cancer?
Frontiers DNA Damage Repair Deficiency in Pancreatic Ductal
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma
Hutch News Fred Hutchinson Cancer Center
Efferocytosis reprograms the tumor microenvironment to promote